NCT02341274View on ClinicalTrials.gov

Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 11, 2016

Primary Completion Date

January 20, 2018

Study Completion Date

January 20, 2018

Conditions

Bioequivalence

Interventions

DRUG

Tacrolimus

Bioequivalence study

Trial Locations (1)

46202

Indiana CTSI Clinical Research Center, Indianapolis

All Listed Sponsors

collaborator

Food and Drug Administration (FDA)

FED

lead

Indiana University

OTHER

NCT02341274 - Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers | Biotech Hunter | Biotech Hunter